Therefore, to identify new biomarkers of an invasive tumor phenotype, which may also constitute a potential new approach for laryngeal cancer treatment, it is necessary to assess the level of O-GlcNAc cycling enzymes in the most frequent cancers of head and neck origin, also with respect to indication of OGT and OGA. The gene discussed is OGT; the disease is neoplasm.